An Experimental New Drug May Soon Make Alzheimer's A Treatable Condition

There’s a lot we don’t know about Alzheimer’s, but a strong theory for its cause is the build-up of amyloid plaques in the brain. Removing those plaques has been a primary focus, with researchers trying everything from ultrasound to snake venom, and one pharmaceutical company, Biogen, might have just cracked the code. Biogen has been working with aducanumab, an antibody that’s shown promise in Alzheimer’s treatment in the past.